News
Teva Completes Acquisition of Theramex
Teva Pharmaceutical Industries Ltd. announced that it has completed the acquisition of Theramex, Merck KGaA's European-based women's health business. Acquisition...
News
Novartis drug Tasigna received approval from the European Commission
Novartis received approval from the European Commission for Tasigna® (nilotinib) as a treatment for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia...
Press Releases
Lundbeck phase III studies confirm nalmefene as efficacious and safe in helping individuals to reduce their alcohol consumption
H. Lundbeck A/S (Lundbeck) announced the completion of two out of three pivotal studies in the phase III clinical programme for nalmefene in alcohol...
Press Releases
Personalised Medicine and Diagnostics Europe 2011
Innovate in an era of cost-effectiveness: Realise the value of personalised medicine Discover how to strengthen your drug pipeline with companion diagnostics How...
Press Releases
King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY
King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. announced that King has resubmitted a New Drug Application (NDA) for REMOXY (oxycodone) to the U.S. Food...
Drug Research
King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. announced that King has resubmitted a New Drug Application (NDA) for REMOXY® (oxycodone) to the U.S. Food...
Clinical Trials
VistaGen Therapeutics Announces Successful Completion of Initial Phase 1 Safety Study of AV-101
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read